GLP-1 Maintenance Dose: Keeping Weight Off on Less
Educational information only. This article does not diagnose, treat, cure or prevent any condition and is not medical advice. All decisions about GLP-1 dosing — including any reduction — should be made with your prescribing clinician.
Once you've reached your goal weight on a GLP-1, stopping cold is rarely the plan. Some clinicians use a reduced maintenance dose to help sustain results — but a lower dose alone is not a guaranteed strategy. The real buffer against regain is the muscle mass and sustainable habits built during the active loss phase.
What a maintenance dose actually means
There is no universally agreed "maintenance dose" protocol for GLP-1 medications — it is not a formally defined phase in all approved prescribing guidelines. What some clinicians do in practice is reduce the dose gradually once a patient reaches their target weight, rather than stopping the medication entirely.
The rationale is straightforward: GLP-1 medications work partly by modulating appetite signalling. When the medication is stopped, appetite returns — often more acutely than before, which is one mechanism behind the regain pattern most people experience after stopping. A lower ongoing dose may partially sustain that appetite regulation.
Whether this approach is right for you is a conversation for you and your clinician. Factors they will weigh include your individual response at lower doses, your cardiovascular and metabolic risk profile, and practical considerations around cost and access.
What the evidence says about dose reduction
Clinical trials that tested stopping or reducing semaglutide showed substantial weight regain in the 12 months following cessation. Reducing rather than stopping entirely may blunt that regain — but the evidence base for a specific reduced maintenance dose is thinner than the evidence for therapeutic doses used during active weight loss. This is a clinician-led decision, not a self-managed one.
Active dose vs maintenance dose: what changes
| Factor | Active (loss) dose | Maintenance dose |
|---|---|---|
| Typical purpose | Achieve target weight; maximum appetite suppression | Sustain achieved weight; reduced appetite modulation |
| Dose level | Titrated to therapeutic range per approved schedule | Lower than therapeutic maximum; clinician-determined |
| Evidence base | Robust phase 3 trial data | Limited; based on clinical practice more than trial data |
| What else you need | Protein, resistance training, habit formation | Preserved muscle mass, sustainable habits — these become the primary defence |
The real buffer: muscle and habits
Research shows that a significant portion of weight lost on a GLP-1 can be lean tissue if people don't actively work to preserve it. And muscle mass is directly relevant to long-term weight maintenance: it supports a healthier resting metabolic rate, makes exercise more sustainable, and changes how your body handles the food you eat.
Whether you're eventually on a lower maintenance dose or have stopped the medication entirely, the outcomes look substantially better for people who:
- Hit a high protein target throughout the active loss phase
- Did consistent resistance training during the loss phase
- Built eating habits and patterns they can sustain without the medication's appetite suppression
A maintenance dose may help. But it is not a substitute for having done the muscle and habit work during the window the drug creates.
Regain risk on any dose reduction
It's important to be clear: regain risk exists on any dose reduction, not just when stopping entirely. If a lower maintenance dose is not sufficient to sustain appetite regulation for a particular individual, weight may return. This is not a personal failure — it reflects the biological mechanisms these medications act on. Coming off any GLP-1 should happen with a plan in place, not as an abrupt stop without clinical support.
Frequently asked
Can you stay on a lower GLP-1 dose once you've reached your goal weight?
Some clinicians do use a reduced maintenance dose once a patient reaches their target — rather than stopping entirely. It is a clinician-led decision based on your individual response and risk of regain. Talk to your doctor about what makes sense for you.
What happens if you stop a GLP-1 completely?
Research shows that most people regain a significant portion of lost weight after stopping, particularly if the muscle mass and habits built during the loss phase aren't in place. The appetite suppression goes away — and the underlying drives return. Stopping is a clinician-led decision; it shouldn't happen without a plan.
Is a maintenance dose guaranteed to prevent regain?
No. A reduced maintenance dose is not a guaranteed strategy for preventing regain — it is one clinical tool. The evidence for durable results points to preserved muscle mass and sustainable habits built during the active loss phase.
What should I do during the active loss phase to protect my results?
The active phase is the window that matters most. Focus on hitting your protein target, doing resistance training 2–3 times a week, and building eating habits you can sustain after the medication is reduced or stopped. These are the factors most associated with durable results.
Educational information only. This article does not diagnose, treat, cure or prevent any condition and is not medical advice. All GLP-1 dosing decisions, including any reduction, should be made with your prescribing clinician.